A Randomized Clinical Trial for GNX80 in Intermittent Claudication
Status:
Not yet recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
This is a Phase 4, randomized clinical trial to evaluate whether GNX80 vs. placebo,
prescribed for 6 months to patients with Intermittent Claudication(IC) would lead to an
improvement in the walking distance.